Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Cash flows from operating activities:
Net loss	$ (14,847,380)	$ (6,998,606)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expense	432,321	3,139,053
Issuance of common stock from equity transaction	0	603,924
Stock-based 401K company common match	19,967	37,080
Depreciation expense	15,608	98,414
Impairment charge - IPR&D	0	2,974,000
Deferred income tax benefit	0	(381,513)
Operating lease expense	160,684	0
Loss on disposal of fixed assets related to lease termination	0	310,951
Write off of remaining ROU asset and lease liability pursuant to a lease termination	0	(32,309)
Bargain purchase gain	0	(13,334,568)
Interest expense from beneficial conversion feature	0	32,953
Increase in warrants liability	0	81,700
Changes in operating assets and liabilities:
Prepaid expenses and other assets	810,797	(1,138,548)
Accounts payable	217,504	(1,977,667)
Accrued expenses	637,682	83,753
Restructuring reserve	(498,185)	(1,572,086)
Operating lease liabilities	(98,133)	0
Net cash used in operating activities	(13,149,135)	(18,073,469)
Cash flows from investing activities:
Cash received in reverse merger transaction	0	29,106,513
Proceeds from sale of equipment	0	275,000
Net cash provided by investing activities	0	29,381,513
Cash flows from financing activities:
Proceeds from exercise of warrants	70,459	0
Proceeds from issuances of common stock	29,756,502	750,000
Net cash provided by financing activities	29,826,961	750,000
Net increase in cash and cash equivalents	16,677,826	12,058,044
Cash and cash equivalents at beginning of period	12,161,739	103,695
Cash and cash equivalents at end of period	28,839,565	12,161,739
Supplemental cash flow information:
Conversion of convertible notes and accrued interest into common stock	0	32,953
Consideration in connection with reverse merger transaction	0	15,793,638
Conversion of warrants liability into additional common stock	$ 0	$ 372,925